Literature DB >> 21832120

Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction.

Mark J McCabe1, Carles Gaston-Massuet, Vaitsa Tziaferi, Louise C Gregory, Kyriaki S Alatzoglou, Massimo Signore, Eduardo Puelles, Dianne Gerrelli, I Sadaf Farooqi, Jamal Raza, Joanna Walker, Scott I Kavanaugh, Pei-San Tsai, Nelly Pitteloud, Juan-Pedro Martinez-Barbera, Mehul T Dattani.   

Abstract

CONTEXT: Fibroblast growth factor (FGF) 8 is important for GnRH neuronal development with human mutations resulting in Kallmann syndrome. Murine data suggest a role for Fgf8 in hypothalamo-pituitary development; however, its role in the etiology of wider hypothalamo-pituitary dysfunction in humans is unknown.
OBJECTIVE: The objective of this study was to screen for FGF8 mutations in patients with septo-optic dysplasia (n = 374) or holoprosencephaly (HPE)/midline clefts (n = 47).
METHODS: FGF8 was analyzed by PCR and direct sequencing. Ethnically matched controls were then screened for mutated alleles (n = 480-686). Localization of Fgf8/FGF8 expression was analyzed by in situ hybridization in developing murine and human embryos. Finally, Fgf8 hypomorphic mice (Fgf8(loxPNeo/-)) were analyzed for the presence of forebrain and hypothalamo-pituitary defects.
RESULTS: A homozygous p.R189H mutation was identified in a female patient of consanguineous parentage with semilobar HPE, diabetes insipidus, and TSH and ACTH insufficiency. Second, a heterozygous p.Q216E mutation was identified in a female patient with an absent corpus callosum, hypoplastic optic nerves, and Moebius syndrome. FGF8 was expressed in the ventral diencephalon and anterior commissural plate but not in Rathke's pouch, strongly suggesting early onset hypothalamic and corpus callosal defects in these patients. This was consolidated by significantly reduced vasopressin and oxytocin staining neurons in the hypothalamus of Fgf8 hypomorphic mice compared with controls along with variable hypothalamo-pituitary defects and HPE.
CONCLUSION: We implicate FGF8 in the etiology of recessive HPE and potentially septo-optic dysplasia/Moebius syndrome for the first time to our knowledge. Furthermore, FGF8 is important for the development of the ventral diencephalon, hypothalamus, and pituitary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832120      PMCID: PMC3417283          DOI: 10.1210/jc.2011-0454

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

Review 1.  Why mutation analysis does not always predict clinical consequences: explanations in the era of genomics.

Authors:  Charles R Scriver
Journal:  J Pediatr       Date:  2002-05       Impact factor: 4.406

2.  The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes.

Authors:  Aimée D C Paulussen; Constance T Schrander-Stumpel; Demis C J Tserpelis; Matteus K M Spee; Alexander P A Stegmann; Grazia M Mancini; Alice S Brooks; Margriet Collée; Anneke Maat-Kievit; Marleen E H Simon; Yolande van Bever; Irene Stolte-Dijkstra; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Anthonie J van Essen; Klaske D Lichtenbelt; Arie van Haeringen; Mei L Kwee; Augusta M A Lachmeijer; Gita M B Tan-Sindhunata; Merel C van Maarle; Yvonne H J M Arens; Eric E J G L Smeets; Christine E de Die-Smulders; John J M Engelen; Hubertus J Smeets; Jos Herbergs
Journal:  Eur J Hum Genet       Date:  2010-06-09       Impact factor: 4.246

Review 3.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

4.  Moebius sequence and hypogonadotrophic hypogonadism.

Authors:  Juliet E Jennings; Colm Costigan; William Reardon
Journal:  Am J Med Genet A       Date:  2003-11-15       Impact factor: 2.802

5.  Mouse GLI3 regulates Fgf8 expression and apoptosis in the developing neural tube, face, and limb bud.

Authors:  Kazushi Aoto; Tamiko Nishimura; Kazuhiro Eto; Jun Motoyama
Journal:  Dev Biol       Date:  2002-11-15       Impact factor: 3.582

6.  Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency.

Authors:  Ericka B Trarbach; Ana Paula Abreu; Leticia Ferreira Gontijo Silveira; Heraldo Mendes Garmes; Maria Tereza M Baptista; Milena Gurgel Teles; Elaine M F Costa; Moosa Mohammadi; Nelly Pitteloud; Berenice B Mendonca; Ana Claudia Latronico
Journal:  J Clin Endocrinol Metab       Date:  2010-05-12       Impact factor: 5.958

7.  FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development.

Authors:  H Ohuchi; Y Hori; M Yamasaki; H Harada; K Sekine; S Kato; N Itoh
Journal:  Biochem Biophys Res Commun       Date:  2000-11-02       Impact factor: 3.575

8.  Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.

Authors:  M T Dattani; J P Martinez-Barbera; P Q Thomas; J M Brickman; R Gupta; I L Mårtensson; H Toresson; M Fox; J K Wales; P C Hindmarsh; S Krauss; R S Beddington; I C Robinson
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

9.  Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE.

Authors:  Jill A Rosenfeld; Blake C Ballif; Donna M Martin; Arthur S Aylsworth; Bassem A Bejjani; Beth S Torchia; Lisa G Shaffer
Journal:  Hum Genet       Date:  2010-04       Impact factor: 4.132

Review 10.  Genetics of septo-optic dysplasia.

Authors:  Daniel Kelberman; Mehul Tulsidas Dattani
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

View more
  40 in total

1.  Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.

Authors:  Taneli Raivio; Magdalena Avbelj; Mark J McCabe; Christopher J Romero; Andrew A Dwyer; Johanna Tommiska; Gerasimos P Sykiotis; Louise C Gregory; Daniel Diaczok; Vaitsa Tziaferi; Mariet W Elting; Raja Padidela; Lacey Plummer; Cecilia Martin; Bihua Feng; Chengkang Zhang; Qun-Yong Zhou; Huaibin Chen; Moosa Mohammadi; Richard Quinton; Yisrael Sidis; Sally Radovick; Mehul T Dattani; Nelly Pitteloud
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

Review 2.  Pituitary gland development and disease: from stem cell to hormone production.

Authors:  Shannon W Davis; Buffy S Ellsworth; María Inés Peréz Millan; Peter Gergics; Vanessa Schade; Nastaran Foyouzi; Michelle L Brinkmeier; Amanda H Mortensen; Sally A Camper
Journal:  Curr Top Dev Biol       Date:  2013       Impact factor: 4.897

3.  Persistent expression of activated notch in the developing hypothalamus affects survival of pituitary progenitors and alters pituitary structure.

Authors:  Paven K Aujla; Vedran Bogdanovic; George T Naratadam; Lori T Raetzman
Journal:  Dev Dyn       Date:  2015-08       Impact factor: 3.780

4.  Midbrain-hindbrain involvement in septo-optic dysplasia.

Authors:  M Severino; A E M Allegri; A Pistorio; B Roviglione; N Di Iorgi; M Maghnie; A Rossi
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-24       Impact factor: 3.825

5.  Astroglial-Mediated Remodeling of the Interhemispheric Midline Is Required for the Formation of the Corpus Callosum.

Authors:  Ilan Gobius; Laura Morcom; Rodrigo Suárez; Jens Bunt; Polina Bukshpun; William Reardon; William B Dobyns; John L R Rubenstein; A James Barkovich; Elliott H Sherr; Linda J Richards
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

Review 6.  Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes.

Authors:  Timothy J Edwards; Elliott H Sherr; A James Barkovich; Linda J Richards
Journal:  Brain       Date:  2014-01-28       Impact factor: 13.501

Review 7.  The origins of the circumventricular organs.

Authors:  Clemens Kiecker
Journal:  J Anat       Date:  2017-12-27       Impact factor: 2.610

8.  Loss-of-function mutations in FGF8 can be independent risk factors for holoprosencephaly.

Authors:  Sungkook Hong; Ping Hu; Erich Roessler; Tommy Hu; Maximilian Muenke
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

Review 9.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

10.  Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism.

Authors:  Brent S Abel; Natalie D Shaw; Jenifer M Brown; Judith M Adams; Teresa Alati; Kathryn A Martin; Nelly Pitteloud; Stephanie B Seminara; Lacey Plummer; Duarte Pignatelli; William F Crowley; Corrine K Welt; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-01-22       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.